INOVIO to Report To start with Quarter 2021 Economical Success on May possibly 10, 2021

PLYMOUTH Meeting, Pa., April 27, 2021 /PRNewswire/ — INOVIO (NASDAQ: INO) announced today that first quarter 2021 money benefits will be launched soon after the industry close on May 10, 2021. Pursuing the launch, INOVIO will host a reside meeting connect with and webcast at 4:30 p.m. ET to examine monetary outcomes and deliver a general enterprise update relating to its DNA Medications System, like the company’s ongoing vaccine developments for COVID-19.

A dwell and archived variation of the audio presentation will be offered on-line at http://ir.inovio.com/occasions-and-displays/default.aspx. This is a hear-only function but will contain a live Q&A with analysts.

About INOVIO

INOVIO is a biotechnology firm concentrated on fast bringing to industry precisely created DNA medications to deal with and defend men and women from infectious illnesses, cancer, and disorders associated with HPV. INOVIO is the 1st and only business to have clinically demonstrated that a DNA medication can be shipped immediately into cells in the body by using a proprietary good system to make a sturdy and tolerable immune reaction. Precisely, INOVIO’s lead prospect VGX-3100 is the to start with DNA medication to obtain efficacy endpoints in a Period 3 clinical demo, Reveal 1, for the remedy of precancerous cervical dysplasia brought on by HPV-16 and/or HPV-18. VGX-3100 also shown optimistic Stage 2 efficacy outcomes in separate trials analyzing the treatment method of precancerous vulvar dysplasia and anal dysplasia. Also in growth are applications targeting HPV-connected cancers and a unusual HPV-connected sickness, recurrent respiratory papillomatosis (RRP) non-HPV-similar cancers glioblastoma multiforme (GBM) and prostate most cancers as properly as externally funded infectious condition DNA vaccine development programs in Zika, Lassa fever, Ebola, HIV, and coronaviruses involved with MERS and COVID-19 disorders. Companions and collaborators include things like Advaccine, ApolloBio Company, AstraZeneca, The Bill & Melinda Gates Basis, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Superior Investigate Initiatives Company (DARPA)/Joint Plan Executive Business office for Chemical, Biological, Radiological and Nuclear Protection (JPEO-CBRND)/Department of Protection (DoD), HIV Vaccines Demo Network, Worldwide Vaccine Institute (IVI), Kaneka Eurogentec, Clinical CBRN Protection Consortium (MCDC), National Cancer Institute, Nationwide Institutes of Health, Nationwide Institute of Allergy and Infectious Disorders, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Existence Sciences, Regeneron, Richter-Helm BioLogics, Thermo Fisher Scientific, College of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. INOVIO also is a proud recipient of 2020 Ladies on Boards “W” designation recognizing corporations with far more than 20% females on their board of administrators. For a lot more info, stop by www.inovio.com.

Story continues

CONTACTS:
Buyers: Ben Matone, 484-362-0076, [email protected]
Media: Jeff Richardson, 267-440-4211, [email protected]

Watch authentic information:http://www.prnewswire.com/news-releases/inovio-to-report-to start with-quarter-2021-monetary-outcomes-on-may possibly-10-2021-301277656.html

Resource INOVIO Prescribed drugs, Inc.